Drug General Information
Drug ID
D0H3SL
Former ID
DNC001026
Drug Name
NK3201
Drug Type
Small molecular drug
Indication Discovery agent Investigative [541640]
Structure
Download
2D MOL

3D MOL

Formula
C31H29N5O6
InChI
InChI=1S/C31H29N5O6/c37-21-34-25-19-33-30(23-12-5-2-6-13-23)36(31(25)41)20-27(39)35-24(18-22-10-3-1-4-11-22)29(40)26(38)14-9-17-42-28-15-7-8-16-32-28/h1-8,10-13,15-16,19,21,24H,9,14,17-18,20H2,(H,34,37)(H,35,39)
InChIKey
QOANBAXBOLUAFA-UHFFFAOYSA-N
CAS Number
CAS 204460-24-2
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Chymase Target Info Inhibitor [535865]
KEGG Pathway Renin-angiotensin system
Reactome Activation of Matrix Metalloproteinases
Metabolism of Angiotensinogen to Angiotensins
WikiPathways ACE Inhibitor Pathway
Metabolism of Angiotensinogen to Angiotensins
References
Ref 541640(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6503).
Ref 535865Impact of chymase inhibitor on cardiac function and survival after myocardial infarction. Cardiovasc Res. 2003 Nov 1;60(2):413-20.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.